Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhangjiagang Freetrade Science And Technology Co Ltd Announces Capital Injection


Wednesday, 17 Apr 2013 08:00pm EDT 

Zhangjiagang Freetrade Science And Technology Co Ltd announced that it has signed a capital injection contract with a Zhangjiagang-based asset operating company (Company A), a Jiangsu-based chemical industry company (Company B) and a Jiangsu-based chemical industry exchange center company (Company C) on April 16, 2013. According to the contract, the Company, Company A and Company B will respectively inject RMB 40 million, RMB 75 million and RMB 80 million into Company C, to increase Company C's registered capital from RMB 5 million to RMB 200 million. After that, Company A's holdings in Company C will decrease from 100% to 40%. The Company and Company B will respectively begin to hold a 40% and a 20% stake in Company C. 

Company Quote